Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

maspin suppresses the invasive phenotype of human breast carcinoma.

Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJ.

Cancer Res. 1998 Dec 15;58(24):5681-5.

2.

Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.

Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, Amir S, Seftor RE, Seftor EA, Hendrix MJ.

Cancer Biol Ther. 2003 Jul-Aug;2(4):398-403.

PMID:
14508113
3.
4.

In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix.

Gui GP, Puddefoot JR, Vinson GP, Wells CA, Carpenter R.

Br J Surg. 1995 Sep;82(9):1192-6.

PMID:
7551993
6.

Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines.

Prasad CP, Rath G, Mathur S, Bhatnagar D, Ralhan R.

Chem Biol Interact. 2010 Feb 12;183(3):455-61. doi: 10.1016/j.cbi.2009.11.019. Epub 2009 Nov 26.

PMID:
19944674
7.

Adhesion and migration of extracellular matrix-stimulated breast cancer.

Bartsch JE, Staren ED, Appert HE.

J Surg Res. 2003 Mar;110(1):287-94.

PMID:
12697413
8.

Negative cooperativity between alpha 3 beta 1 and alpha 2 beta 1 integrins in human mammary carcinoma MDA MB 231 cells.

Lichtner RB, Howlett AR, Lerch M, Xuan JA, Brink J, Langton-Webster B, Schneider MR.

Exp Cell Res. 1998 May 1;240(2):368-76.

PMID:
9597010
9.

p53 regulates the expression of the tumor suppressor gene maspin.

Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S.

J Biol Chem. 2000 Mar 3;275(9):6051-4.

10.

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R.

Science. 1994 Jan 28;263(5146):526-9.

PMID:
8290962
11.

Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.

Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.

Toxicol Appl Pharmacol. 2008 Jan 15;226(2):178-91. Epub 2007 Sep 21.

PMID:
17961621
13.

Maspin sensitizes breast carcinoma cells to induced apoptosis.

Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S.

Oncogene. 2002 Jun 13;21(26):4089-98.

14.

Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.

van der Pluijm, Vloedgraven H, Papapoulos S, Löwick C, Grzesik W, Kerr J, Robey PG.

Lab Invest. 1997 Dec;77(6):665-75.

PMID:
9426405
15.

Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.

Shi HY, Stafford LJ, Liu Z, Liu M, Zhang M.

Cell Motil Cytoskeleton. 2007 May;64(5):338-46.

PMID:
17301947
16.

Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells.

Jia Y, Zeng ZZ, Markwart SM, Rockwood KF, Ignatoski KM, Ethier SP, Livant DL.

Cancer Res. 2004 Dec 1;64(23):8674-81.

17.

Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors.

Kousidou OC, Mitropoulou TN, Roussidis AE, Kletsas D, Theocharis AD, Karamanos NK.

Int J Oncol. 2005 Apr;26(4):1101-9.

PMID:
15754008
19.

The paradoxical expression of maspin in ovarian carcinoma.

Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA, Hendrix MJ.

Clin Cancer Res. 2002 Sep;8(9):2924-32.

20.

Maspin inhibits cell migration in the absence of protease inhibitory activity.

Bass R, Fernández AM, Ellis V.

J Biol Chem. 2002 Dec 6;277(49):46845-8. Epub 2002 Oct 15.

Supplemental Content

Support Center